Secondaries announced 9.30.2015
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Medgenics Symbol: MDGN Price: Last trade $7.79 Trade Date: 10/1 Shares: TBD Underwriter(s) Piper Jaffray, JMP Securities CoManager(s) Needham & Co.[…]
